NEW YORK, March 17, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully...
Tiziana Life Sciences is an England-based biotechnology company that researches and develops immunotherapies for the treatment of neurodegenerative diseases.